Crossref
FDA Drug Development Approval Process: Compromising Safety for Speed
Harvard Undergraduate Health Policy Review · 2025 · 25 (1)
DOI: 10.56927/668426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Harvard Undergraduate Health Policy Review, 2025. Verfasst von Airi Furui.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Furui, A. (2025). FDA Drug Development Approval Process: Compromising Safety for Speed. Harvard Undergraduate Health Policy Review, 25(1). https://doi.org/10.56927/668426
Vancouver
Furui A. FDA Drug Development Approval Process: Compromising Safety for Speed. Harvard Undergraduate Health Policy Review. 2025;25(1). doi:10.56927/668426
BibTeX
@article{Furui2025,
author = {Furui, Airi},
title = {FDA Drug Development Approval Process: Compromising Safety for Speed},
journal = {Harvard Undergraduate Health Policy Review},
year = {2025},
volume = {25},
number = {1},
doi = {10.56927/668426}
}
EUVIMED